@misc{indiciae85d38c1a113d,
  title = {Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial.},
  author = {Jeremy S Abramson and Susan Geyer and Sharmila Giri and Levi Pederson and Ann Hudson and Eric D Hsi and Neha Mehta-Shah and Patrick M Reagan and Richard L Deming and Richard F Little and Steven Gore and Shira N Dinner and Anusha Vallurupalli and Daniel J Landsburg and Brad Kahl and Jonathan W Friedberg and Nancy L Bartlett and John P Leonard},
  year = {2026},
  doi = {10.1016/s2352-3026(26)00191-2},
  url = {https://pubmed.ncbi.nlm.nih.gov/42660130/},
  note = {Source identifier: 42660130}
}